Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chenghua Xu has a total of 142 co-authors. Here are the top co-authors by number of shared publications:

  • Chuan-Qi Liu

    Air Environmental Modeling and Pollution Controlling Key Laboratory of Sichuan Higher Education Institutes, Chengdu University of Information Technology, Chengdu 610225, China

    3 shared publications
  • Anyang Tao

    Taizhou First People’s Hospital, Wenzhou Medical University, Taizhou, China

    2 shared publications
  • Feng Gao

    Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    2 shared publications
  • Jiangxian Ying

    Taizhou First People’s Hospital, Wenzhou Medical University, Taizhou, China

    2 shared publications
  • Jianying Liu

    Chengdu University of Information Technology

    2 shared publications
  • Lei Li

    Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    2 shared publications

Latest Publications

  • Therapeutic effect of rescue stent implantation on acute intracranial atherosclerotic disease-related large vessel occlusion

    by Chengju Wang, Anyang Tao, Jiangxian Ying, Xinliang Wang, Congguo Yin, Chenghua Xu

    Introduction The effectiveness and safety of acute intracranial atherosclerotic disease-related large vessel occlusion (ICAD-LVO) stenting are still up for debate. We conducted a comparative analysis between patients who had successful mechanical thrombectomy (MT) and the group that rescue stent placement following MT failure. Methods Our study included 1125 patients who underwent thrombectomy between January 2020 and December 2024 at 2 centres in Zhejiang, China. Among them, the number of ICAD-LVO patient cases was 430, which were divided into the group with MT alone group and the group with rescue stent after failed thrombectomy. The two groups were balanced through the use of propensity score matching. The primary outcome was a modification of the Rankin Scale (mRS) at 90 days, which measured the change in disability. We measured the secondary outcomes of symptomatic intracranial haemorrhage (sICH), 90-day mortality and good functioning and independence (defined as a 90-day mRS score of 0 to 2). Results Our results showed no statistical differences between the good 90-day mRS score, sICH incidence, and 90-day mortality between the rescue stent group and the successful MT group. In addition, we found that stent placement after multiple thrombectomies reduced the 90-day good functional prognosis (mRS 0–2), which was statistically significant (aOR, 0.43 [95% CI, 0.22–0.85]; P = 0.02). Conclusions Our study indicates rescue stenting after failed MT can yield outcomes similar to successful MT. In addition, our study showed that good outcome of placing a rescue stent after 1 failed thrombectomy is better than after multiple thrombectomies.

  • Open Access

    A Frequency–Severity Analysis of Irrigation Demand Deficits Using Optimal Framework Under Uncertainty

    by Xu Chenghua, Xu Nian, He Yuan, Mahdi Moudi

    Demand for irrigation water varies substantially between upstream and downstream reaches of river basins due to spatial variability in rainfall, agro-climatic situations, and management practices. Upstream areas often experience over-irrigation and waterlogging, while downstream regions are challenged with water scarcity, timing mismatches, and allocation conflicts. This study proposes a novel SWAT–AquaCrop–optimization nexus framework to minimize both the frequency (DDF) and severity (DDS) of irrigation demand deficit under hydro-climatic uncertainty. To enhance numerical stability and a realistic representation of system stress, deficit frequency is formulated using a smooth, differentiable exceedance function instead of conventional binary thresholds. The framework integrates SWAT-based hydrological projections with AquaCrop simulations of crop yield and evapotranspiration-driven water demand, simultaneously evaluating three interlinked objectives: allocation-disparity deficit (equity), yield deficit (productivity), and irrigation-efficiency deficit (operational performance). Hydro-climatic uncertainty is represented through a quantile-based classification, with favorable (S1), normal (S2), and extreme (S3) scenarios defined by the 33rd and 66th percentiles of the time-varying deficit ratio. The results indicate that stage-specific irrigation timing adjustments (advanced by 2–5 days) better align water applications with peak crop water requirements during flowering and grain-filling stages. This enhances downstream reliability, mitigates upstream over-irrigation, and substantially reduces both demand deficit frequency and severity.


  • Endovascular Recanalization versus Medical Treatment Alone for Symptomatic Nonacute Intracranial Artery Occlusion: A Multicenter Cohort Study

    by Lei Li, Zhaoxuan Yan, Qi Wu, Haoquan Sun, Jianjia Han, Lan Ma, Yingchun Wu, Ludi Fu, Yan Liu, Chenghua Xu, et al.

    Study findings demonstrated that medical treatment alone was associated with better clinical outcomes compared with endovascular recanalization plus medical treatment in patients with symptomatic nonacute intracranial artery occlusion.


  • Bailout Intracranial Angioplasty or Stenting After Thrombectomy for Acute Large Vessel Occlusion: 1-Year Outcomes of ANGEL-REBOOT

    by Feng Gao, Xu Tong, Ming Wei, Xiaoxi Yao, Lei Li, Yuesong Pan, Baixue Jia, Thanh N. Nguyen, Ming Yang, Dapeng Sun, et al.

    BACKGROUND: The long-term benefits of bailout intracranial angioplasty or stenting (BAOS) after thrombectomy in patients with acute large vessel occlusion remain unclear. This study compared BAOS with standard therapy in patients with large vessel occlusion with unsuccessful recanalization (expanded Thrombolysis In Cerebral Infarction score 0–2a) or >70% residual stenosis after thrombectomy. METHODS: ANGEL-REBOOT (Randomized Study of Bailout Intracranial Angioplasty Following Thrombectomy for Acute Large Vessel Occlusion) was a multicenter, open-label, blinded–end point, randomized trial conducted across 36 Chinese hospitals. Patients ≥18 years of age with anterior or posterior circulation large vessel occlusion within 24 hours of stroke onset were enrolled. After identification of thrombectomy failure or high-grade residual stenosis, patients were randomly assigned to the BAOS group (intervention) or the standard therapy group (control), in which thrombectomy was continued or terminated. The use of tirofiban was permitted in both groups during and after the procedure. In the intention-to-treat population, the primary outcome was analyzed using an assumption-free ordinal analysis (Wilcoxon-Mann-Whitney test) to compare the modified Rankin Scale scores (ordinal variable ranging from 0 to 6) between groups at 1-year follow-up, from which the generalized odds ratio was derived. Secondary outcomes included stroke recurrence in the treated artery and all-cause mortality within 1 year, analyzed using Cox proportional hazards models. RESULTS: A total of 348 patients were randomly assigned (176 to the BAOS group and 172 to the standard therapy group) and followed for 90 days, from December 19, 2021, to June 2, 2023. Of these, 326 patients (166 in the BAOS group and 160 in the standard therapy group) completed the 1-year follow-up. Compared with standard therapy, BAOS significantly improved the 1-year modified Rankin Scale score distribution (generalized odds ratio, 1.34 [95% CI, 1.05–1.73]; P =0.02). Fewer stroke recurrences in the treated artery occurred in the BAOS group than in the standard therapy group (7 of 166 [4%] versus 21 of 160 [13%]; hazard ratio, 0.30 [95% CI, 0.13–0.71]; P =0.006). One-year mortality rates were similar between groups (25 of 166 [15%] versus 27 of 160 [17%]; hazard ratio, 0.87 [95% CI, 0.50–1.50]). CONCLUSIONS: Among Chinese patients with large vessel occlusion with unsuccessful recanalization or high-grade residual stenosis after thrombectomy, BAOS was associated with reduced disability and stroke recurrence after 1 year compared with standard therapy. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05122286.


  • Open Access

    Recent Developments in Catalytic Carbonyl Sulfur Hydrolysis

    by Zongshe Liu, Yinjuan Dong, Chenghua Xu, Feng Chen, Wenzhu Liu, Yan Yang, Lingyu Guo

    Carbonyl sulfide (COS) is the most abundant and longest-lasting organic reduced sulfur compound in the atmosphere. Removing it is a critical and challenging aspect in desulfurization technology in order to comply with global restrictions on harmful emissions. Catalytic hydrolysis refers to the process whereby COS reacts with water under the influence of a catalyst to generate carbon dioxide and hydrogen sulfide. Due to its high conversion rate, minimal side reactions, no hydrogen consumption, and mature technology, it has emerged as the most crucial COS removal method at present. Since its inception in the 1940s, research on the catalytic hydrolysis of COS has witnessed encouraging progress over the past several decades. This review summarizes recent advancements in this field. In this review, the evaluation metrics, influencing factors, and reaction mechanism for the COS hydrolysis reaction are briefly introduced. The recent advancements in COS hydrolysis catalysts in recent years are emphasized. Additionally, the existing challenges and potential solutions in this field are also proposed. Finally, the future development directions for this research area are envisioned. The purpose of this review is to offer a reference for the subsequent design and research of high-activity and high-stability hydrolysis catalysts.


  • Open Access

    Structural Effect of Cu-Mn/Al2O3 Catalysts on Enhancing Toluene Combustion Performance: Molecular Structure of Polyols and Hydrothermal Treatment

    by Junjie Li, Wenjing Chen, Chenghua Xu, Xiaoxiao Hou, Xiaodong Hu

    This study presents a series of Cu-Mn/Al2O3 catalysts prepared by the polyol method to improve the toluene combustion process. The catalytic activity evaluation results showed that the different polyols have a great influence on catalyst activity, in which the catalyst prepared with glycerol through a hydrothermal reaction at 90 °C displayed the highest catalytic activity. The lowest T90 and T50 values could be achieved by CMA-GL-90 with 260 and 237 °C, respectively. Moreover, the XRD and BET results showed that the hydrothermal treatment was more favorable with Cu-Mn crystal formation, and an abundance of mesopores remained in all catalysts with a high specific surface area from 94.37 to 123.03 m2·g−1. The morphology analysis results by SEM and TEM indicated that employing glycerol coupled with hydrothermal treatment at 90 °C could enhance the formation of CuMn2O4 spinel. The toluene catalytic combustion mechanism of Cu-Mn/Al2O3 catalysts was discussed based on XPS and H2-TPR, and a high atomic ratio of Mn3+ could be obtained with 51.03%, and the ratio of Oads/Olatt also increased to 2.85 in CMA-GL-90. The increase in Mn3+ species and oxygen vacancies on the surface of catalysts exhibited excellent activity and stability for toluene combustion. These findings offer valuable insights for optimizing the design and application of Cu-Mn/Al2O3 catalysts in addressing the catalytic oxidation reactions of organic volatile compounds.


  • Open Access

    The Efficacy and Safety of Tirofiban Use in Endovascular Thrombectomy for Intravenous Thrombolysis Applicable Patients with Large Vessel Occlusion Stroke—a Post Hoc Analysis from the Direct-MT Trial

    by Yingying Zhang, Ping Zhang, Anyang Tao, Xinliang Wang, Jiangxian Ying, Zhimin Wang, Pengfei Yang, Yongwei Zhang, Lei Zhang, Zifu Li, et al.

    Purpose: The purpose of the study was to evaluate the efficacy and safety of tirofiban use in endovascular thrombectomy for intravenous thrombolysis applicable patients of large vessel occlusion stroke with data from Direct-MT trial. Materials and Methods: Direct-MT was the first randomized controlled trial to prove the non-inferiority of thrombectomy alone to bridging therapy (intravenous thrombolysis before thrombectomy) for large vessel occlusion stroke. Patients who underwent endovascular procedure were included and divided into thrombectomy-alone group and bridging therapy group. The effect of tirofiban use on 90 days MRS distribution, MRS 0–2 and mortality, successful reperfusion, the ASPECTS and outcome lesion volume of index stroke, re-occlusion of the treated vessel, futile recanalization and safety outcomes were further evaluated in both groups after adjustment for relevant confounding factors. The interaction between tirofiban and rt-PA was also assessed. Results: Of 639 patients included in this analysis, 180 patients underwent thrombectomy with tirofiban use (28.2%). Patients with tirofiban use had lower percentage of bridging therapy (41.1% vs 54.3%, P = 0.003), higher proportion of large artery atherosclerosis (P < 0.001) and more emergent stenting (30.56% vs 6.97%, P < 0.001). After adjustment for confounding factors, the 90-day modified Rankin Scale distribution, successful final recanalization rate, outcome lesion volume of index stroke on CT and intracranial hemorrhage risk showed no difference after tirofiban use in thrombectomy-alone group and in bridging therapy group. No interaction effect between tirofiban and rt-PA was detected. Conclusion: Based on data from Direct-MT trial, tirofiban is a safe medication for intravenous thrombolysis applicable patients with large vessel occlusion stroke undergoing thrombectomy. Level of Evidence: Level 3, cohort study of randomized trial.


  • Open Access

    1,4-Butanediol Selective Dehydration to 3-Butene-1-ol over Ca–Zr–Sn Composite Oxide Catalysts

    by Hao Dong, Cheng-Hua Xu, Fang-Lu Yang, Lei Du, Chen-Long Liu, Wen-Jing Chen, Lin Wang

    Ca–Zr–Sn composite oxides catalysts for 1,4-butanediol (BDO) selective dehydration to 3-butene-1-ol (BTO) are synthesized by impregnation and co-precipitation in the present work. The results show that Ca–Zr–Sn catalysts prepared from co-precipitation by using NaOH-Na2CO3 mixing alkali solution as precipitant exhibit an excellent catalytic property for BDO dehydration to BTO. For instance, Ca–Zr–Sn oxide with Ca/Zr and Sn/Zr molar ratio of 0.68 and 0.28 calcined at 650 °C gives a BDO conversion and BTO selectivity of about 97% and 82%, respectively, and exhibits no deactivation during 1000 h scale-up experimental testing. X-ray diffraction results indicate that catalytic active centers for BDO dehydration to BTO are from Ca0.15Zr0.85O crystal phase. NH3- and CO2-temperature programmed desorption prove that the surface of obtained catalysts can provide a large amount of acid and base sites simultaneously. FT-IR spectra of pyridine-adsorbed samples show that acid sites on the surface of Ca–Zr–Sn oxide catalyst mainly exist in a state of Lewis acid, which activates terminal -OH groups of BDO molecule through complexing. The activated -OH interacts with β-H activated on base sites O2− anions relative to Ca species, thereby the CH2=CH- bonds are produced through dehydration to form BTO.


  • Design strategy of bifunctional catalysts for CO oxidation

    by Yulu Liu, Chenghua Xu, Wanglai Cen, Hao Li